Protagonist Therapeutics, Inc.PTGXNASDAQ
LOADING
|||
Valuation Context
Market Cap
$5.2B
Mid Cap
P/E (TTM)
115.4x
Elevated
P/S (TTM)
24.8x
Elevated
EV/EBITDA
184.9x
Elevated

A smaller-scale business, with exceptional profitability priced at a premium.

Explore metrics